Completed
Safety and Tolerability of Single and Multiple Doses of VAK694 in Healthy and Atopic Subjects
NCT00620230
- Conditions
- Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +7 more
- Locations
-
- Novartis Investigator Site North Miami Beach, Florida, United States